Back to search results

Study of RestoreMe Mobile App for Cancer Patients

This study is looking at how cancer patients use a comprehensive mobile app called RestoreMe. The app is designed to help you with diet, nutrition, and activity during your treatment. We want to see if patients will use the app regularly throughout their treatment. The goal is for the app to provide helpful information that can improve your health understanding and behaviors. You may be able to join if you are 18 or older, have certain types of cancer (brain, head and neck, lung, breast, prostate, gastrointestinal, or gynecological), and are planning to receive or have received radiation therapy. We will measure how satisfied you are with the app at the end of your treatment or up to 12 months after joining.

Study design
This is an interventional study planning to enroll 50 participants. It is not specified if it is randomized or blinded.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your satisfaction will be measured at the completion of your treatment regimen or up to 12 months after joining the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06860425

Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity

Recruiting
NAAges 18+InterventionalHealth services
Montefiore Medical Center
~50 participants
Updated 2026-02-24 on ClinicalTrials.gov
What's tested:RestoreMe

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Patient Satisfaction
Measured over Upon completion of treatment regimen or up to 12 months (+/1 month) after study entry

Conditions

Mobile Applications
Cancer Patients

Explore related trials

Breast CarcinomaLung CarcinomaMalignant Brain NeoplasmMalignant Digestive System NeoplasmMalignant Female Reproductive System NeoplasmMalignant Head and Neck NeoplasmProstate Carcinoma

Where it's being run

1 sites across 1 states
New York1

Study leadership

  • Rafi Kabarriti, MD · PRINCIPAL_INVESTIGATOR · Montefiore Medical Center

Who to contact

Rafi Kabarriti, MD
[email protected]
914-629-7743
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Diagnosis of invasive malignancy of the brain, head and neck region, lung, breast (DCIS and invasive disease allowed), prostate, gastrointestinal system or gynecological region
Planned to receive, or have received, radiation therapy treatment with curative intent
Note: Patients undergoing systemic therapy are eligible
Note: Any dose/fractionation of curative-intent radiation therapy is eligible
Patients must have a smartphone or other device with the ability to receive text messages, download and use mobile applications
Eastern Cooperative Oncology Group (ECOG) performance status 0-2
Ability to read and write in English
Provide written informed consent to participate in the study o NOTE: Patients enrolled on another clinical trial are eligible

Exclusion

Metastatic cancer
Undergoing treatment with palliative intent
Poorly controlled diabetes (defined as fasting glucose level \> 200 mg/dL despite attempts to improve glucose control by fasting duration and adjustment of medications)
Uncontrolled hypertension
Any medical condition requiring fluid restriction or nutrient restrictions

What this trial measures

  • Patient SatisfactionUpon completion of treatment regimen or up to 12 months (+/1 month) after study entry

    Patient satisfaction with the RestoreMe app will be measured using the Technology Acceptability Survey (TAS). The TAS consists of 10 questions including 7 quantitative items which will be used to assess Patient Satisfaction for the purposes of the study. Each of the 7 quantitative items on the survey represent a unique satisfaction parameter and are scored on a 5-point ordinal scale ranging from 1-5. Lower scores for an item correlate with increased satisfaction with the specific parameter and higher scores for an item correlate with decreased satisfaction for the specific parameter, yielding an overall possible scoring range of 7-35. Group scores will be summarized using basic descriptive statistics.